HLA-Dw1 and BfF as protective markers in multiple sclerosis

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

1965 • 1,402 citations

HISTOCOMPATIBILITY TESTING, 1972

1974 • 1,267 citations

GENETIC POLYMORPHISM IN HUMAN GLYCINE-RICH BETA-GLYCOPROTEIN

1972 • 528 citations

Mixed Lymphocyte Cultures with Inbred Individuals: An Approach to MLC Typing

1973 • 108 citations

HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes

1982 • 108 citations

HLA-TYPING IN MULTIPLE SCLEROSIS SIBLING PAIRS

1982 • 87 citations

HLA family studies and multiple sclerosis: A common gene, dominantly expressed

1981 • 82 citations

Studies on epidemiological, clinical and etiological aspects of multiple sclerosis.

1969 • 71 citations

HLA-linked and unlinked determinants of multiple sclerosis

1982 • 71 citations

The epidemiology of multiple sclerosis in Finland: increase of prevalence and stability of foci in high-risk areas

1983 • 44 citations

Strong Linkage Disequilibrium between HLA—Dw2 and BfS in Multiple Sclerosis and in the Normal Population

1979 • 36 citations

Lymphocyte blast transformation responses and viral antibodies in relation to HLA antigens in multiple sclerosis

1981 • 34 citations

OPTIC NEURITIS AND MULTIPLE SCLEROSIS: DO FACTOR B ALLELES INFLUENCE PROGRESSION OF DISEASE?

1981 • 31 citations

Normal distribution of factor B (Bf) allotypes in multiple sclerosis

1981 • 6 citations